Home
>
National Drug Code (NDC)
>
Cloderm
Cloderm - 13548-031-45 - (clocortolone pivalate)
Drug Information of Cloderm
| Product NDC: | 13548-031 |
| Proprietary Name: | Cloderm |
| Non Proprietary Name: | clocortolone pivalate |
| Active Ingredient(s): | .001 g/g & nbsp; clocortolone pivalate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cloderm
| Product NDC: | 13548-031 |
| Labeler Name: | Coria Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017765 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19770822 |
Package Information of Cloderm
| Package NDC: | 13548-031-45 |
| Package Description: | 45 g in 1 TUBE (13548-031-45) |
NDC Information of Cloderm
| NDC Code | 13548-031-45 |
| Proprietary Name | Cloderm |
| Package Description | 45 g in 1 TUBE (13548-031-45) |
| Product NDC | 13548-031 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | clocortolone pivalate |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 19770822 |
| Marketing Category Name | NDA |
| Labeler Name | Coria Laboratories |
| Substance Name | CLOCORTOLONE PIVALATE |
| Strength Number | .001 |
| Strength Unit | g/g |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
